1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. PAI-1

PAI-1 (纤溶酶原激活物抑制物1)

Plasminogen activator inhibitor-1 (PAI-1) is the primary inhibitor of tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA), and functionally serves to suppress tissue and plasma fibrinolysis.

PAI-1 is a member of the serpin family of proteins and exists in multiple conformations of which a minor component, the “active” form, exhibits inhibitory effects against tPA and uPA.

PAI-1 is an endogenous inhibitor of urokinase-type plasminogen activator (uPA), and its expression is regulated by a number of intrinsic factors (e.g., cytokines and growth factors) and extrinsic factors (e.g., cellular stress).

PAI-1 seems to play a pivotal role in tumor growth and may represent a potential therapeutic target for bladder cancer.

PAI-1 相关产品 (7):

Cat. No. Product Name Effect Purity
  • HY-15253
    Tiplaxtinin Inhibitor 98.42%
    Tiplaxtinin 是一种有效的,具有口服活性的选择性的纤溶酶原激活物抑制剂-1 (PAI-1) 抑制剂,IC50 为 2.7 μM。
  • HY-100447
    TM5275 sodium Inhibitor 98.97%
    TM5275 sodium是纤溶酶原激活物抑制剂 (PAI-1),IC50值为6.95 μM。
  • HY-N1504
    Loureirin B Inhibitor 99.99%
    Loureirin B 是从剑叶龙血树中分离到的黄酮类化合物,为 PAI-1 的抑制剂,IC50 值为 26.10 μM;Loureirin B 同时可以抑制 KATP,以及 ERKJNK 的磷酸化,具有抗糖尿病的功效。
  • HY-101214
    UK-371804 Inhibitor ≥98.0%
    UK-371804是尿嘧啶型纤溶酶原激活物 (uPA) 的抑制剂,Ki值为10 nM。
  • HY-100415
    UKI-1 Inhibitor
    UKI-1 (UKI-1C) 是一种有效的尿激酶型纤溶酶原激活剂 (uPA) 抑制剂,Ki 为 0.41 μM。UKI-1 还是一种低分子量的丝氨酸蛋白酶 (serine protease) 抑制剂。UKI-1 是有效的抗转移剂,可抑制癌细胞的侵袭能力。
  • HY-P2230
    Angstrom6 Inhibitor 99.70%
    Angstrom6 (A6 Peptide) 是一种来源于单链尿激酶纤溶酶原激活剂 (scuPA) 的8个氨基酸的肽,可干扰 uPA/uPAR 级联反应并消除下游效应。Angstrom6 与 CD44 结合,抑制肿瘤细胞的迁移、侵袭和转移,调节 CD44 介导的细胞信号。
  • HY-N0518
    Toddalolactone Inhibitor ≥99.0%
    Toddalolactone,Toddalia asiatica 的主要成分,抑制重组人纤溶酶原激活物抑制物-1 (PAI-1) 的活性, IC50 为 37.31 μM。
Isoform Specific Products

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.